Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
The Marygold Companies | MGLD | 14. nov 2024 | 1.34 | +3.88 |
The ODP | ODP | 14. nov 2024 | 25.37 | +1.81 |
The OLB Group | OLB | 14. nov 2024 | 1.85 | -7.73 |
The Oncology Institute | TOI | 14. nov 2024 | 0.24 | -10.84 |
The ONE Group Hospitality | STKS | 14. nov 2024 | 2.98 | -3.87 |
The Pennant Group | PNTG | 14. nov 2024 | 31.90 | -2.74 |
The Real Brokerage | REAX | 14. nov 2024 | 5.17 | -1.71 |
The Real Estate Select Sector SPDR Fund | XLRE | 14. nov 2024 | 42.93 | -0.90 |
The RealReal | REAL | 14. nov 2024 | 3.99 | -3.62 |
The RMR Group A | RMR | 14. nov 2024 | 22.52 | -1.18 |
The Shyft Group | SHYF | 14. nov 2024 | 14.13 | -1.74 |
The Trade Desk A | TTD | 14. nov 2024 | 125.88 | -1.08 |
The9 ADR | NCTY | 14. nov 2024 | 11.30 | +11.99 |
TherapeuticsMD | TXMD | 14. nov 2024 | 1.46 | -2.48 |
Theratechnologies | THTX | 14. nov 2024 | 1.21 | -0.82 |
Theravance Biopharma | TBPH | 14. nov 2024 | 9.57 | -1.14 |
Theriva Biologics | TOVX | 14. nov 2024 | 1.35 | -4.93 |
Thermo Fisher Scientific | TMO | 14. nov 2024 | 533.02 | -1.64 |
Thermon Group | THR | 14. nov 2024 | 29.61 | -0.94 |
Third Coast Bancshares | TCBX | 14. nov 2024 | 34.67 | -0.86 |
Third Harmonic | THRD | 14. nov 2024 | 12.90 | -9.41 |
Thomson Reuters | TRI | 14. nov 2024 | 164.74 | -2.17 |
Thor Industries | THO | 14. nov 2024 | 109.42 | +0.70 |
Thornburg Income Builder Opportunities Fund | TBLD | 14. nov 2024 | 16.67 | +0.73 |
Thoughtworks | TWKS | 14. nov 2024 | 4.47 | 0.00 |
ThredUp A | TDUP | 14. nov 2024 | 0.93 | +2.49 |
Thryv | THRY | 14. nov 2024 | 13.99 | -1.27 |
Thumzup Media | TZUP | 14. nov 2024 | 3.83 | 0.00 |
Thunder Bridge Capital Partners IV SPAC A | THCP | 14. nov 2024 | 11.15 | +3.62 |
Thunder Power | AIEV | 14. nov 2024 | 0.30 | -0.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.